Docetaxel (Teva Parenteral Medicines, Inc.)
Welcome to the PulseAid listing for the Docetaxel drug offered from Teva Parenteral Medicines, Inc.. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Parenteral Medicines, Inc. |
NON-PROPRIETARY NAME: | Docetaxel |
SUBSTANCE NAME: | DOCETAXEL ANHYDROUS |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-02-11 |
END MARKETING DATE: | 0000-00-00 |
Docetaxel HUMAN PRESCRIPTION DRUG Details:
Item Description | Docetaxel from Teva Parenteral Medicines, Inc. |
LABELER NAME: | Teva Parenteral Medicines, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2016-02-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0703-5720_041cf665-2c3c-4c18-b7c8-d774e00d5aea |
PRODUCT NDC: | 0703-5720 |
APPLICATION NUMBER: | ANDA203877 |
Other DOCETAXEL ANHYDROUS Pharmaceutical Manufacturers / Labelers: